Assessing the use of a smartphone application to support adherence to inhaled corticosteroids, i.e. preventer/controller inhalers, in young adults (18-30 years) with asthma
Not Applicable
Completed
- Conditions
- AsthmaRespiratory
- Registration Number
- ISRCTN11295269
- Lead Sponsor
- ational University of Ireland
- Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34468325/ (added 02/09/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
1. Age between 18-30 years on date of recruitment
2. Diagnosis of asthma
3. Current prescription for any form of ICS
4. Own a smartphone
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Usability of the app is measured using the System Usability Scale (SUS) at 2-week follow-up<br> 2. Acceptability of the app measured using questions modified from previous feasibility studies of mHealth interventions (Huang et al., 2019; Zhang et al., 2019) at 2-week follow-up<br> 3. Feasibility of the app measured using frequently used questions modified from previous feasibility studies of mHealth interventions (Edbrooke-Childs et al., 2019; Escobar-Viera et al., 2020; Hightow-Weidman et al., 2018; Huang et al., 2019; Zhang et al., 2019) at 2-week follow-up<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Source of recruitment measured by asking participants how they heard about the study at baseline<br> 2. Attrition measured using the number of participants who consent to participate and who remain in the study until the end of follow-up at 2 weeks<br> 3. Adherence to ICS measured using the Medication Adherence Report Scale for Asthma (MARS-A) at baseline and 2-week follow-up<br> 4. Asthma control measured using the Asthma Control Test (ACT) at baseline and 2-week follow-up<br>